AMMAN — In a proactive effort to improve healthcare affordability
and accessibility,
Jordan's Food and Drug Administration joined forces with the
National Consumer Protection Association and the Ibssar
Conferences and Seminars Foundation. Together, they hosted a workshop focusing
on drug pricing policies and consumer protection.
اضافة اعلان
In this collaborative initiative, experts and
representatives from the Consumer Protection Association actively participated
in the National Committee responsible for reviewing
drug pricing principles.
The aim is to ensure collective decision-making that takes into account the
interests of various sectors, Hala News reported.
The institution's ongoing action plan
includes
regular reviews of medication costs, aligning with the nation's
objective to make essential medications affordable for all citizens.
Health and consumer rights, including the
need for comprehensive health insurance and affordable access to essential
healthcare, were emphasized by Dr. Abdel Fattah Al-Kilani, head of the
Health Committee at the
National Consumer Protection Association.
Meanwhile,
Dr. Wassim Al-Najami, president of the Jordanian Association of Pharmaceutical
Manufacturers, highlighted the
pharmaceutical industry's role in ensuring
competitive drug prices, local production of alternative therapies, and job
creation.
The workshop,
covering drug pricing policies, pharmaceutical economics, and consumer
protection, concluded with key participants presenting recommendations.
Read more National news
Jordan News
.jpg)
.jpg)
